Qualification of Digital Endpoints for Regulatory Decision-Making
Why validation produces the evidence — and qualification is the separate regulatory decision that the evidence is fit for a defined context of use.
REGULATORY OPERATIONSA verified and validated digital measure is not, by that fact alone, ready to carry a regulatory endpoint: qualification is a separate decision for a stated context of use.
Getting it wrong is rarely recoverable — a COU too broad or a population mismatched at submission cannot be repaired with data already collected. Define the context of use before the evidence, size verification, analytical and clinical validation to it, choose the pathway, and fix the COU and the bar with the regulator before pivotal data.
There is no single route: the pathway follows the context of use and whether qualification must be reusable
Formal public programme — Biomarker, COA, Animal Model and ISTAND — fixing a COU other programmes may rely on.
Qualification opinion, advice or letter of support for a specified COU; source of the only qualified digital endpoint, SV95C.
Device-side counterpart; the precedent is Apple’s Atrial Fibrillation History Feature, qualified 1 May 2024.
Justified for one trial through a formal Center meeting or EMA scientific advice; still built to the COU.
Available only where the COU matches exactly.
Four assertions that separate a validated measure from a qualified endpoint
Validation asks whether the measure is trustworthy; qualification asks whether it may decide this regulatory question. “Validated” is a property of the measure; “qualified” of its use for a stated COU.
A measure is never qualified in general — only for this concept, population, disease, decision and stage. Change the COU and the qualification does not automatically follow.
V3 — verification, analytical and clinical validation, plus V3+ usability — is the structure; the COU sets how much of each. A primary-endpoint or label-claim COU attracts the fullest package.
A device or sensor change, an algorithm update, population or COU drift, or real-world deployment conditions can disturb the binding and should trigger re-confirmation.
Five steps, in the order the qualification is built
- 1Define the context of use in six fields: measure, concept, population and disease, decision, development stage, conditions of use.
- 2Map evidence to the COU — verification, analytical validation, clinical validation and usability, sized per the V3+ framework.
- 3Choose the pathway: FDA DDT, FDA MDDT on the device side, EMA qualification, study-specific justification or reliance.
- 4Engage the regulator early — a formal Center meeting, DDT interaction, EMA qualification advice or scientific advice — before generating data.
- 5Maintain the qualification: re-confirm whenever the measure, device, population or COU changes.
s.507 FD&C Act (DDT: Biomarker, COA, Animal Model, ISTAND) · FDA MDDT · EMA qualification of novel methodologies · EMA/CHMP/SAWP/178058/2019 · FDA DHT guidance (s.IV.C.3) · FDA patient-focused drug development guidance series · V3 / V3+ framework
© qointa 2026 – Public – Uncontrolled when printed · Not legal advice; this summary does not classify any device.
sales@qointa.com · qointa.com
More from the library
Digital Health Technologies in Clinical Trials — A Regulatory Position-Paper Series
One device, several perimeters: a framework for assessing the regulatory impact of the technologies a trial relies on.
Read more →Who Is the Manufacturer? Economic-Operator Roles in DHT Supply Chains
How provisioning, importing, kitting and modifying a device assign manufacturer, importer and distributor duties — often by operation of law.
Read more →You Can Delegate the Work, Not the Accountability: Vendor Qualification and Oversight under ICH E6(R3)
The sponsor’s duty to qualify and oversee its DHT vendors — distinct from who holds the economic-operator role.
Read more →Talk to a specialist
Bring one device and one protocol — a wearable, a sensor, an app, anything. We will tell you which regulatory perimeters it opens and what it takes to close them.
Book a 15-minute call